NINDS Neuroscience Funding Announcements

Preclinical Therapeutics Development for NeuroAIDS
Funding Contact: NINDS Funding Coordinator
Funding Categories: Neural Environment

Brief Description:
The purpose of this Program Announcement is to encourage the development and/or validation of new in vitro and in vivo models of HIV or HAART-related neurotoxicity that show promise for use in the screening of novel CNS and PNS-targeted therapeutic compounds. Ideally, such models would facilitate the screening of compounds or therapeutic approaches which protect neuronal and glial cells of the CNS from damage in response to HIV and possibly other stresses, such as injury or associated inflammatory insults.

Grant Mechanism: R21
NIH Guide: PA-06-139
Release Date: 2006-02-16
Expiration Date: 2006-08-21

Grant Mechanism: R03
NIH Guide: PA-06-140
Expiration Date: 2006-08-21